3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
11
Stomach Neoplasms
6
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Gastric Adenocarcinoma
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Gastric Cancer
2
Adenocarcinoma
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Radioactive Iodine-refractory Differentiated Thyroid Cancer
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Malignant Neoplasms of Digestive Organs
1
Liver Neoplasms
1
Gestational Trophoblastic Disease
1
Gastrointestinal Stromal Tumors
1
Fludzoparib" and Anti-angiogenic
1
Colonic Neoplasms
1
Cirrhosis, Familial, with Pulmonary Hypertension
1
Advanced Primary Liver Cancer
1
Advanced Biliary Tract Carcinoma
1
Adebrelimab
1
Interventions
pembrolizumab
4
lenvatinib
3
Magnetic Resonance Spectroscopy
3
Specimen Handling
2
Nivolumab
2
Epirubicin
2
regorafenib
1
gallium 68 PSMA-11
1
enfortumab vedotin
1
anlotinib
1
amivantamab
1
abemaciclib
1
Tablets
1
Surveys and Questionnaires
1
Standard of Care
1
Radiosurgery
1
Pemetrexed
1
Observation
1
Ipilimumab
1
Imatinib Mesylate
1
Glutamate Carboxypeptidase II
1
Cyclophosphamide
1
Combined Modality Therapy
1
Carboplatin
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
BMS-906024
1
68Ga-DKFZ-PSMA-11
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
apatinib
×
1 year
×
Clear all
No trials found.